Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Interest & Investment Income (2019 - 2025)

Catheter Precision (VTAK) has disclosed Interest & Investment Income for 7 consecutive years, with $10000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest & Investment Income rose 42.86% to $10000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $65000.0, a 35.64% decrease, with the full-year FY2024 number at $81000.0, down 76.66% from a year prior.
  • Interest & Investment Income was $10000.0 for Q3 2025 at Catheter Precision, up from $3000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $119000.0 in Q2 2023 to a low of -$41000.0 in Q4 2022.
  • A 5-year average of $30733.3 and a median of $18000.0 in 2025 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: tumbled 99.12% in 2021, then surged 231.71% in 2023.
  • Catheter Precision's Interest & Investment Income stood at $1000.0 in 2021, then plummeted by 4200.0% to -$41000.0 in 2022, then soared by 231.71% to $54000.0 in 2023, then plummeted by 37.04% to $34000.0 in 2024, then tumbled by 70.59% to $10000.0 in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Interest & Investment Income are $10000.0 (Q3 2025), $3000.0 (Q2 2025), and $18000.0 (Q1 2025).